Rhona Stein
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 43
- Radiopharmaceutical Chemistry and Applications 37
- Immunology 20
- Macrophage Migration Inhibitory Factor 10
- Immune Cell Function and Interaction 5
- Co-authors
- David M. GoldenbergHans J. HansenRobert M. SharkeyThomas M. CardilloSusan ChenM. Jules MattesChien‐Hsing ChangJ. D. Burton
- Journals
- Blood (14 papers)Clinical Cancer Research (7 papers)International Journal of Cancer (6 papers)Cancer (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Rhona Stein
78 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 101
- Radiology, Nuclear Medicine and Imaging 1.8k
- Oncology 1.3k
- Immunology 832
- Pathology and Forensic Medicine 669
- Genetics 323
Countries citing papers authored by Rhona Stein
This map shows the geographic impact of Rhona Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhona Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhona Stein more than expected).
Fields of papers citing papers by Rhona Stein
This network shows the impact of papers produced by Rhona Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhona Stein. The network helps show where Rhona Stein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rhona Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 2011 | 7 | |
| 3 | 2010 | 39 | |
| 4 | Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. | 2010 | 33 |
| 5 | 2010 | 19 | |
| 6 | 2009 | 57 | |
| 7 | 2008 | 49 | |
| 8 | 2007 | 1 | |
| 9 | 2004 | 45 | |
| 10 | Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. | 2002 | 175 |
| 11 | 2001 | 12 | |
| 12 | 1997 | 70 | |
| 13 | 1997 | 19 | |
| 14 | 1995 | 74 | |
| 15 | 1994 | 16 | |
| 16 | 1994 | 30 | |
| 17 | 1993 | 41 | |
| 18 | 1993 | 67 | |
| 19 | 1993 | 73 | |
| 20 | 1992 | 13 |
About Rhona Stein
Rhona Stein is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Pathology and Forensic Medicine, Oncology and Hematology, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (43 papers), Radiopharmaceutical Chemistry and Applications (37 papers), Lymphoma Diagnosis and Treatment (17 papers), Glycosylation and Glycoproteins Research (16 papers), Macrophage Migration Inhibitory Factor (10 papers), HER2/EGFR in Cancer Research (9 papers), Peptidase Inhibition and Analysis (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.8k citations), Oncology (1.3k citations), Immunology (832 citations), Pathology and Forensic Medicine (669 citations) and Genetics (323 citations). Rhona Stein has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include David M. Goldenberg, Hans J. Hansen, Robert M. Sharkey, Thomas M. Cardillo, Susan Chen, M. Jules Mattes, Chien‐Hsing Chang, J. D. Burton, Serengulam V. Govindan and Zhengxing Qu. Their work appears in journals such as Blood, Clinical Cancer Research, International Journal of Cancer, Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.